Bioengineering a humanized 3D tri-culture osteosarcoma model to assess tumor invasiveness and therapy response
- 1 October 2021
- journal article
- research article
- Published by Elsevier in Acta Biomaterialia
- Vol. 134, 204-214
Abstract
No abstract availableKeywords
Funding Information
- H2020 European Research Council (ERC\u20102017\u2010PoC\u2010789760)
- European Research Council
- Fundação para a Ciência e a Tecnologia (CEECIND/02713/2017)
- Fundação para a Ciência e a Tecnologia (SFRH/BD/144640/2019)
- Foundation for Science and Technology (POCI-01-0145-FEDER-022122)
This publication has 73 references indexed in Scilit:
- Osteosarcoma treatment – Where do we stand? A state of the art reviewCancer Treatment Reviews, 2014
- Embedded multicellular spheroids as a biomimetic 3D cancer model for evaluating drug and drug-device combinationsBiomaterials, 2014
- Doxorubicin has in vivo toxicological effects on ex vivo cultured mesenchymal stem cellsToxicology Letters, 2014
- Influence of tumour micro-environment heterogeneity on therapeutic responseNature, 2013
- Proteomic approach toward molecular backgrounds of drug resistance of osteosarcoma cells in spheroid culture systemProteomics, 2013
- Impact of the 3D Microenvironment on Phenotype, Gene Expression, and EGFR Inhibition of Colorectal Cancer Cell LinesPLOS ONE, 2013
- Tumor stroma as targets for cancer therapyPharmacology & Therapeutics, 2013
- Doxorubicin Caused Apoptosis of Mesenchymal Stem Cells via p38, JNK and p53 PathwayCellular Physiology and Biochemistry, 2013
- Osteosarcoma incidence and survival rates from 1973 to 2004Cancer, 2009
- Murine bone marrow–derived mesenchymal stem cells as vehicles for interleukin‐12 gene delivery into Ewing sarcoma tumorsCancer, 2008